Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

ONFI Drug Profile

« Back to Dashboard

What is the patent landscape for Onfi, and what generic Onfi alternatives are available?

Onfi is a drug marketed by Lundbeck Pharms Llc and is included in two NDAs.

The generic ingredient in ONFI is clobazam. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the clobazam profile page.

Summary for Tradename: ONFI

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list21
Clinical Trials: see list3
Patent Applications: see list1,385
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ONFI at DailyMed

Pharmacology for Tradename: ONFI

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Mechanism of ActionCytochrome P450 2D6 Inhibitors
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lundbeck Pharms Llc
ONFI
clobazam
TABLET;ORAL202067-001Oct 21, 2011DISCNNoNo► Subscribe► Subscribe
Lundbeck Pharms Llc
ONFI
clobazam
SUSPENSION;ORAL203993-001Dec 14, 2012RXYesYes► Subscribe► Subscribe
Lundbeck Pharms Llc
ONFI
clobazam
TABLET;ORAL202067-002Oct 21, 2011RXYesNo► Subscribe► Subscribe
Lundbeck Pharms Llc
ONFI
clobazam
SUSPENSION;ORAL203993-001Dec 14, 2012RXYesYes► Subscribe► Subscribe
Lundbeck Pharms Llc
ONFI
clobazam
TABLET;ORAL202067-001Oct 21, 2011DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot